This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Inclacumab

Roche Holding AG

Drug Names(s): Roche 3, R1512, RO4905417, RG1512

Description: R1512 is a fully human antibody targeting P-selectin, a cell adhesion molecule found in cells lining blood vessels and activated platelets. P-selectin recruits white blood cells to the site of injury as part of the inflammatory process.

Deal Structure: R1512 was created by Genmab under a collaboration with Roche.

Partners: Genmab A/S


Inclacumab News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug